Biogen investors unmoved as drugmaker reports sales gains, failed trial
October 23, 2018 at 11:56 AM EDT
Biogen reported a 12 percent increase in third quarter revenue compared to the same period last year. But a clinical setback dampened investors' enthusiasm.
